LAWRENCE S. LEWIN - Corporate Board Profile

abrdn Healthcare Investors

Filing Date	Source Excerpt
2001-05-15	LAWRENCE S. LEWIN** (62), Formerly Chief Executive Officer (from 1970-1999) of The Lewin Group (healthcare public policy and management consulting), a subsidiary of Quintiles Transnational Corp.; Director (since 1989) of Apache Medical Systems; Director (from 1996-1999) of Quintiles Transnational Corp.; and Trustee (since 1987) of HQH, (since 1992) of HQL and Chairman (since 2000) of HQH and of HQL.
2002-05-17	LAWRENCE S. LEWIN (63), Formerly Chief Executive Officer (from 1970-1999) of The Lewin Group (healthcare public policy and management consulting), a subsidiary of Quintiles Transnational Corp.; and Trustee (since 1987) of HQH, (since 1992) of HQL and Chairman (since 2000) of HQH and of HQL.
2003-05-12	LAWRENCE S. LEWIN (64), Formerly Chief Executive Officer (from 1970-1999) of The Lewin Group (healthcare public policy and management consulting), a subsidiary of Quintiles TransnationalCorp.; and Trustee (since 1987) of HQH, (since 1992) of HQL and Chairman (since 2000) of HQH and of HQL.
2004-05-24	LAWRENCE S. LEWIN^+ (66), 3305 ROLLING ROAD, CHEVY CHASE, MD 20815 Trustee of HQH (since 1987) and of HQL (since 1992) and Chairman of HQH and HQL (since 2000), Executive Consultant (since December 1999); Chief Executive Officer (from 1970-1999) of The Lewin Group (healthcare public policy and Management consulting), a subsidiary of Quintiles Transnational Corp.; Director (since 2003) of Medco Health Solutions, Inc. * Trustee considered to be an "interested person" within the meaning of the Investment Company Act of 1940, as amended (the "1940 Act"), through position or affiliation with Hambrecht & Quist Capital Management LLC (the "Adviser"). ** Member of each Fund's Audit Committee. # Member of each Fund's Valuation Committee. ^ Member of each Fund's Corporate Governance and Nominating Committee. + Member of each Fund's Qualified Legal Compliance Committee. The members of each Fund's Nominating and Governance Committee are Messrs. Lewin and Termeer and Dr. Mack. Mr. Lewin is the Chairman of each Fund's Nominating and Governance Committee. The members of each Fund's QLCC are Messrs. Lewin, Oddleifson and Pohotsky. For the fiscal year ended September 30, 2003, the Independent Trustees as a group received $136,980 from HQH and $134,714 from HQL for fees and reimbursed expenses. The following table sets forth information regarding compensation of Trustees by the Funds for the fiscal year ended September 30, 2003, but does not include expenses. Lawrence S. Lewin $24,000 from each Fund, total $48,000.
2005-05-10	LAWRENCE S. LEWIN^~+ (67), 3305 ROLLING ROAD, CHEVY CHASE, MD 20815 Trustee of HQH (since 1987) and of HQL (since 1992) and Chairman of HQH and HQL (since 2000); ... * Member of each Fund's Qualified Legal Compliance Committee. ^ Member of each Fund's Governance Committee. ~ Member of each Fund's Nominating Committee. + Member of each Fund's Qualified Legal Compliance Committee. ... COMPENSATION TABLE ... Lawrence S. Lewin $25,500 from each fund, total $51,000.
2006-05-08	Lawrence S. Lewin (68), Trustee of HQH (since 1987) and of HQL (since 1992) and Chairman of HQH and HQL (since 2000); Executive Consultant (since December 1999) of the Lewin Group... Member of each Fund's Governance Committee, Nominating Committee, Qualified Legal Compliance Committee... Compensation Table: $54,000 total compensation.
2007-05-10	Lawrence S. Lewin (69), 30 Rowes Wharf, Boston, MA 02110 Trustee of HQH (since 1987) and of HQL (since 1992) and Chairman of HQH and HQL (since 2000); Executive Consultant (since December 1999) of the Lewin Group (healthcare public policy and management consulting); Director (since 2001) of CardioNet; Director (since 2003) of Medco Health Solutions, Inc.; Director (October 2005 to November 2006) of Care Fusion and Director (since 1984) of Intermountain Healthcare (non-profit organization).
2008-05-05	Lawrence S. Lewin (70), Chairman of HQH and HQL (since 2000); Member of each Fund's Governance Committee; Member of each Fund's Nominating Committee; Member of each Fund's Qualified Legal Compliance Committee; Total Compensation from both Funds and Fund Complex Paid to Trustees: $55,500.
2009-05-01	Lawrence S. Lewin (71), Chairman of HQH and HQL (since 2000), Trustee of HQH and HQL; Member of each Fund's Governance Committee; Member of each Fund's Nominating Committee; Member of each Fund's Qualified Legal Compliance Committee; Compensation: $56,500 total from both Funds.
2010-04-27	Lawrence S. Lewin (72), Chairman, HQH and HQL; Member of each Fund's Governance Committee; Member of each Fund's Nominating Committee; Member of each Fund's Qualified Legal Compliance Committee; Compensation: $55,500 total from both Funds.
2011-06-08	Mr. Lewin serves as Chairman of the Board of Trustees and Chairman of the Governance and Nominating Committees. ... The members of the Fund's Governance Committee are Dr. Jain, Mr. Lewin and Ms. Stebbins. Mr. Lewin is the Chairman of the Fund's Governance Committee. ... The members of the Fund's Nominating Committee are Dr. Jain, Mr. Lewin and Ms. Stebbins. Mr. Lewin is the Chairman of the Fund's Nominating Committee. ... The members of the Fund's QLCC are Messrs. Lewin, Oddleifson and Pohotsky. Mr. Pohotsky is the Chairman of the Fund's QLCC. ... Compensation Table ... Lawrence S. Lewin ... Total Compensation ... $57,000
2012-04-30	Lawrence S. Lewin, MBA: Mr. Lewin serves as Chairman of the Board of Trustees and Chairman of the Governance and Nominating Committees. Mr. Lewin was the Chief Executive Officer for 30 years of the Lewin Group, which he founded in 1970.

abrdn Life Sciences Investors

Filing Date	Source Excerpt
2001-05-15	LAWRENCE S. LEWIN** (62), Formerly Chief Executive Officer (from 1970-1999) of The Lewin Group (healthcare public policy and management consulting), a subsidiary of Quintiles Transnational Corp.; Director (since 1989) of Apache Medical Systems; Director (from 1996-1999) of Quintiles Transnational Corp.; and Trustee (since 1987) of HQH, (since 1992) of HQL and Chairman (since 2000) of HQH and of HQL.
2002-05-17	LAWRENCE S. LEWIN (63), Formerly Chief Executive Officer (from 1970-1999) of The Lewin Group (healthcare public policy and management consulting), a subsidiary of Quintiles Transnational Corp.; and Trustee (since 1987) of HQH, (since 1992) of HQL and Chairman (since 2000) of HQH and of HQL.
2004-05-24	LAWRENCE S. LEWIN^+ (66), 3305 ROLLING ROAD, CHEVY CHASE, MD 20815 Trustee of HQH (since 1987) and of HQL (since 1992) and Chairman of HQH and HQL (since 2000), Executive Consultant (since December 1999); Chief Executive Officer (from 1970-1999) of The Lewin Group (healthcare public policy and Management consulting), a subsidiary of Quintiles Transnational Corp.; Director (since 2003) of Medco Health Solutions, Inc. * Trustee considered to be an "interested person" within the meaning of the Investment Company Act of 1940, as amended (the "1940 Act"), through position or affiliation with Hambrecht & Quist Capital Management LLC (the "Adviser"). ** Member of each Fund's Audit Committee. # Member of each Fund's Valuation Committee. ^ Member of each Fund's Corporate Governance and Nominating Committee. + Member of each Fund's Qualified Legal Compliance Committee. The members of each Fund's Nominating and Governance Committee are Messrs. Lewin and Termeer and Dr. Mack. Mr. Lewin is the Chairman of each Fund's Nominating and Governance Committee. The members of each Fund's QLCC are Messrs. Lewin, Oddleifson and Pohotsky. Mr. Pohotsky is the Chairman of each Fund's QLCC. For the fiscal year ended September 30, 2003, the annual fee was $15,000. Trustees of each Fund are also paid $1,000 for each Board and Committee meeting attended in person and $500 for each Board and Committee meeting attended by telephone. The Chairman of the Board of Trustees of each Fund receives an additional annual fee of $2,500, the Chairman of each Committee receives an additional annual fee of $1,500 and each Committee member receives an additional annual fee of $500. Independent Trustees as a group received $136,980 from HQH and $134,714 from HQL for fees and reimbursed expenses. The following table sets forth information regarding compensation of Trustees by the Funds for the fiscal year ended September 30, 2003, but does not include expenses. Lawrence S. Lewin $24,000 from each Fund, total $48,000.
2005-05-10	LAWRENCE S. LEWIN^~+ (67), 3305 ROLLING ROAD, CHEVY CHASE, MD 20815 Trustee of HQH (since 1987) and of HQL (since 1992) and Chairman of HQH and HQL (since 2000); Executive Consultant (since December 1999); Director (since 2003) of Medco Health Solutions, Inc.; Chief Executive Officer (from 1970-1999) of The Lewin Group (healthcare public policy and Management consulting), a subsidiary of Quintiles Transnational Corp. * Trustee considered to be an "interested person" within the meaning of the Investment Company Act of 1940, as amended (the "1940 Act"), through position or affiliation with Hambrecht & Quist Capital Management LLC (the "Adviser"). ** Member of each Fund's Audit Committee. ^ Member of each Fund's Governance Committee. ~ Member of each Fund's Nominating Committee. # Member of each Fund's Valuation Committee. + Member of each Fund's Qualified Legal Compliance Committee. For the fiscal year ended September 30, 2004 each Fund paid its Independent Trustees an annual fee of $20,000. Each Fund currently pays each Independent Trustee $500 for each Board and Committee meeting attended in person and $250 for each Board and Committee meeting attended by telephone. For the fiscal year ended September 30, 2004 Independent Trustees of each Fund were paid $1,000 for each Board and Committee meeting attended in person and $500 for each Board and Committee meeting attended by telephone. Currently, the Chairman of the Board of Trustees, the Chairman of the Audit Committee and the Chairman of the Valuation Committee of each Fund receives an additional annual fee of $2,500. Currently, the Chairman of the Nominating Committee and the Chairman of the Governance Committee of each Fund receives an additional fee of $1,500. During the fiscal year ended September 30, 2004 the Chairman of each Committee received an additional fee of $1,500. Independent Trustees are also reimbursed for travel expenses incurred in connection with attending such meetings. For the fiscal year ended September 30, 2004, the Independent Trustees as a group received $169,608 from HQH and $167,490 from HQL for fees and reimbursed expenses. Neither of the Funds directly paid any additional compensation to the Trustees for the fiscal year ended September 30, 2004. Neither of the Funds directly paid any compensation to any officer in excess of $60,000 for the fiscal year ended September 30, 2004. Trustees and officers of the Funds who hold positions with the Adviser receive indirect compensation from the Funds in the form of the investment advisory fee paid to the Adviser. The following table sets forth information regarding compensation of Trustees by the Funds for the fiscal year ended September 30, 2004, but does not include expenses. COMPENSATION TABLE For the fiscal year ended September 30, 2004 NAME OF TRUSTEE FROM EACH FUND TOTAL COMPENSATION FROM BOTH FUNDS AND FUND COMPLEX Lawrence S. Lewin $25,500 $51,000
2006-05-08	Lawrence S. Lewin (68), Trustee of HQH (since 1987) and of HQL (since 1992) and Chairman of HQH and HQL (since 2000); Executive Consultant (since December 1999) of the Lewin Group... The members of each Fund's Governance Committee are Messrs. Lewin and Termeer and Dr. Mack. Mr. Lewin is the Chairman of each Fund's Governance Committee... The members of each Fund's Nominating Committee are Messrs. Lewin and Termeer and Dr. Mack. Mr. Lewin is the Chairman of each Fund's Nominating Committee... The members of each Fund's QLCC are Messrs. Lewin, Oddleifson and Pohotsky. Mr. Pohotsky is the Chairman of each Fund's QLCC... Compensation Table: Lawrence S. Lewin $54,000 total compensation.
2007-05-10	Lawrence S. Lewin (69), 30 Rowes Wharf, Boston, MA 02110 Trustee of HQH (since 1987) and of HQL (since 1992) and Chairman of HQH and HQL (since 2000); Executive Consultant (since December 1999) of the Lewin Group (healthcare public policy and management consulting); Director (since 2001) of CardioNet; Director (since 2003) of Medco Health Solutions, Inc.; Director (October 2005 to November 2006) of Care Fusion and Director (since 1984) of Intermountain Healthcare (non-profit organization). Member of each Fund's Governance Committee. Member of each Fund's Nominating Committee. Member of each Fund's Qualified Legal Compliance Committee.
2008-05-05	Lawrence S. Lewin (70), Chairman of HQH and HQL (since 2000); Member of each Fund's Governance Committee; Member of each Fund's Nominating Committee; Member of each Fund's Qualified Legal Compliance Committee; Total Compensation from both Funds and Fund Complex Paid to Trustees: $55,500.
2009-05-01	Lawrence S. Lewin (71), Chairman of HQH and HQL (since 2000); Member of each Fund's Governance Committee; Member of each Fund's Nominating Committee; Member of each Fund's Qualified Legal Compliance Committee; Compensation: $56,500 total from both Funds.
2010-04-27	Lawrence S. Lewin (72), Chairman, HQH and HQL (since 2000); Member of each Fund's Governance Committee; Member of each Fund's Nominating Committee; Member of each Fund's Qualified Legal Compliance Committee; Compensation: $55,500 total from both Funds.
2011-06-08	Lawrence S. Lewin, MBA: Mr. Lewin serves as Chairman of the Board of Trustees and Chairman of the Governance and Nominating Committees. Mr. Lewin was the Chief Executive Officer for 30 years of the Lewin Group, which he founded in 1970.
2012-04-30	Lawrence S. Lewin, MBA: Mr. Lewin serves as Chairman of the Board of Trustees and Chairman of the Governance and Nominating Committees. Mr. Lewin was the Chief Executive Officer for 30 years of the Lewin Group, which he founded in 1970. The Lewin Group, a healthcare public policy and management consulting firm, delivers objective analyses and strategic counsel to public agencies, nonprofit organizations, industry associations and private companies across the United States. Mr. Lewin provides the Fund valuable insights into healthcare economics and reform.